Related Experiment Video
Updated: Mar 20, 2026

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
Published on: October 6, 2022
Improved Synthesis and In Vitro Evaluation of an Aptamer Ribosomal Toxin Conjugate
Linsley Kelly1, Christina Kratschmer1, Keith E Maier1
1Department of Biochemistry, Albert Einstein College of Medicine , Bronx, New York City, New York.
Abstract:
Delivery of toxins, such as the ricin A chain, Pseudomonas exotoxin, and gelonin, using antibodies has had some success in inducing specific toxicity in cancer treatments. However, these antibody-toxin conjugates, called immunotoxins, can be bulky, difficult to express, and may induce an immune response upon in vivo administration. We previously reported delivery of a recombinant variant of gelonin (rGel) by the full-length prostate-specific membrane antigen (PSMA) binding aptamer, A9, to potentially circumvent some of these problems. Here, we report a streamlined approach to generating aptamer-rGel conjugates utilizing a chemically synthesized minimized form of the A9 aptamer. Unlike the full-length A9 aptamer, this minimized variant can be chemically synthesized with a 5' terminal thiol. This facilitates the large scale synthesis and generation of aptamer toxin conjugates linked by a reducible disulfide linkage. Using this approach, we generated aptamer-toxin conjugates and evaluated their binding specificity and toxicity. On PSMA(+) LNCaP prostate cancer cells, the A9.min-rGel conjugate demonstrated an IC50 of ∼60 nM. Additionally, we performed a stability analysis of this conjugate in mouse serum where the conjugate displayed a t1/2 of ∼4 h, paving the way for future in vivo experiments.
Insights
Researchers developed a streamlined method for creating aptamer-toxin conjugates for cancer therapy. This new approach uses a minimized aptamer for efficient delivery of toxins like gelonin to prostate cancer cells.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Therapeutics
Background:
- Antibody-toxin conjugates (immunotoxins) show promise in cancer treatment but face challenges like bulkiness and immunogenicity.
- Previous work utilized a full-length aptamer (A9) to deliver recombinant gelonin (rGel) to prostate-specific membrane antigen (PSMA)-expressing cells.
- A need exists for more streamlined and scalable methods for generating aptamer-toxin conjugates.
Purpose of the Study:
- To develop a simplified and scalable method for generating aptamer-rGel conjugates.
- To evaluate the binding specificity and toxicity of the novel aptamer-toxin conjugate.
- To assess the in vitro stability of the conjugate for potential in vivo applications.
Main Methods:
- Chemically synthesized a minimized A9 aptamer with a 5' terminal thiol.
- Generated aptamer-toxin conjugates using a reducible disulfide linkage.
- Assessed conjugate binding specificity and cytotoxicity on PSMA(+) LNCaP prostate cancer cells.
- Performed serum stability analysis of the conjugate in mouse serum.
Main Results:
- The A9.min-rGel conjugate demonstrated specific binding and toxicity against PSMA(+) LNCaP cells with an IC50 of approximately 60 nM.
- The conjugate exhibited a half-life (t1/2) of approximately 4 hours in mouse serum.
- The streamlined chemical synthesis facilitated large-scale production of the aptamer-toxin conjugate.
Conclusions:
- A minimized aptamer approach offers an efficient and scalable method for producing aptamer-toxin conjugates.
- The A9.min-rGel conjugate shows potential for targeted cancer therapy due to its specificity and stability.
- This strategy paves the way for further in vivo studies and development of novel targeted cancer treatments.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Improving Translational Accuracy
Inhibitors of Bacterial Protein Synthesis
Experimental RNAi

